INmune Bio Inc. Common stock

INMB

...

INMB: INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Show INMB Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of INMB by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by INMB's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on INMB's company Twitter account

WallStreetBets

Number of mentions of INMB in WallStreetBets Daily Discussion

INMB News

Recent insights relating to INMB

CNBC Recommendations

Recent picks made for INMB stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in INMB

Corporate Flights

Flights by private jets registered to INMB